John Paulson’s Sanofi SNY Stock Holding History

John Paulson’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-52,000	Closed	-$2.49M	–	83
2017 Q2	$2.49M	Sell	52,000 -98,000	-65%	-$4.68M	0.03%	90
2017 Q1	$6.79M	Sell	150,000 -103,000	-41%	-$4.37M	0.09%	64
2016 Q4	$10.2M	Sell	253,000 -164,000	-39%	-$6.46M	0.13%	64
2016 Q3	$15.9M	Buy	417,000 +21,500	+5%	+$863K	0.17%	51
2016 Q2	$16.6M	Buy	+395,500	New	+$16.2M	0.17%	46

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

John Paulson's SNY Position: Q3 2017 in Review

John Paulson sold out of Sanofi (SNY) in Q3 2017, closing a stake of 52,000 shares — an estimated $2.49M sold.

John Paulson first reported a position in SNY in Q2 2016 and held it in 5 quarters. The position peaked at $16.6M in Q2 2016. 485 funds tracked by Wall St. Rank hold SNY as of Q3 2017.

John Paulson reported no remaining Sanofi position as of Q3 2017 after selling out during the quarter.
John Paulson sold 52,000 Sanofi shares in Q3 2017, an estimated $2.49M.
John Paulson first reported a position in Sanofi in Q2 2016 and held it in 5 quarters.
John Paulson's Sanofi position peaked at $16.6M in Q2 2016.
485 funds tracked by Wall St. Rank held Sanofi as of Q3 2017.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.